MET-Positive Lung Cancer Clinical Trials

Are you a cancer patient diagnosed with MET-positive lung cancer who is seeking options? Massive Bio can help you to access the latest clinical trials.

Compliance and Security Certifications

Scroll down to learn more
[EN] Ads Landing Pages - United States & Canada - English
Let's Explore Your Options

Your Birthday

By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Massive Bio has onboarded over 160,000 cancer patients to find their clinical trial

If your doctor has told you that your lung cancer is MET-positive, it means that you either have too many copies of the MET gene (which is relatively unusual) or that gene has a DNA error called MET exon 14 skipping (which is more common). If you have this MET exon 14 error, cells can’t get rid of growth-promoting MET proteins in an orderly way, which causes them to fuel the spread of cancer.

Having this MET mutation is associated with lung cancer that’s challenging to treat. However, several new drugs that target the MET gene alteration are now available. And new therapies that work by addressing problems caused by having too many copies of MET and MET exon 14 skipping are being studied in clinical trials.

Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new options. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important option for many cancer patients.

We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.

MET-Positive Lung Cancer Clinical Trials

If your doctor has told you that your lung cancer is MET-positive, it means that you either have too many copies of the MET gene (which is relatively unusual) or that gene has a DNA error called MET exon 14 skipping (which is more common). If you have this MET exon 14 error, cells can’t get rid of growth-promoting MET proteins in an orderly way, which causes them to fuel the spread of cancer.

Having this MET mutation is associated with lung cancer that’s challenging to treat. However, several new drugs that target the MET gene alteration are now available. And new therapies that work by addressing problems caused by having too many copies of MET and MET exon 14 skipping are being studied in clinical trials.

Dr. Arturo Loaiza Bonilla explains:

What Are Clinical Trials?

Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new options. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important option for many cancer patients.

We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.

MET-Positive Lung Cancer Clinical Trials
Dr.Arturo explains: What Are Clinical Trials?
Find Your Options Now
An MET-positive lung cancer clinical trial may be an option for you
1
Consent Signed

Fill out our contact form and sign our consent form

2
Data Collection

We collect your medical records securely

3
Pre Screening

Our expert nurses check clinical trials and contact you

4
Concierge Services

We support you with appointments, travel, and accommodation

Let’s explore your options and bring new hope to your journey.

We offer a quick, easy and FREE way to find MET-positive lung cancer clinical research opportunities for patients like you. With our unique clinical trial matching system (CTMS) and team specialized in oncology, we can rapidly match you to a clinical research study for those diagnosed with MET-positive lung cancer.

[EN] Ads Landing Pages - United States & Canada - English
Let's Explore Your Options

Your Birthday

By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.
Frequently asked questions

To enroll in clinical trial, you must meet highly specific criteria that’s established by the researchers who are conducting the investigation. That includes detailed information about type of cancer, treatment history, response to treatment, and other data that is collected in medical records.

If you are being treated for cancer or any other disease, your doctor should have a complete record of your medical care, including specific information about what form of the disease you have and what treatments you have received. Your patient relations coordinator will contact you and inform you about the details.

Massive Bio provides its services to the patients and their doctors at no cost—you won’t have to pay anything to receive a clinical-research matching report. There are no hidden costs involved.

Massive Bio strictly adheres to all HIPAA guidelines and international regulations focused on maintaining your privacy. We take extra measures to secure your personal information, ensuring it is protected beyond the mandatory requirements.

Your doctor may know of a clinical research study being conducted in your area that’s recruiting participants and is right for you. However, Massive Bio uses its artificial intelligence powered platform to match patients to clinical research studies that give you the best chance of a positive outcome and are being conducted in a geographical location that makes sense for you.

Yes, Massive Bio keeps your doctor up to date on your status throughout your participation.